2021 年 56 巻 2 号 p. 141-147
Pancreatic islet transplantation is an ideal minimally invasive treatment for patients with severe type 1 diabetes who suffer from glycemic control. However, it is crucial for islet transplantation to combine with regenerative medicine to expand this attractive treatment to more patients with severe diabetes in the future. In order to achieve an effective fusion of islet transplantation and regenerative medicine, it may be of great importance to create radical innovation in each of the following three fields: Improvement of the subcutaneous islet transplantation method, Prevention or reduction of the side effects of immunosuppressive drugs, and Construction of insulin-producing cells.
